BLM and Miyoshi myopathy: Finally, based on our previous observation of a synergy between ML216 and melphalan (Figure 6), we hypothesized that the inhibition of BLM could increase the sensitivity of cells to melphalan, notably in melphalan-resistant MM cells, which would be of therapeutic interest.